Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92.4M
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
9.93M
-
Shares change
-
+987K
-
Total reported value, excl. options
-
$150M
-
Value change
-
+$15M
-
Number of buys
-
22
-
Number of sells
-
-18
-
Price
-
$15.15
Significant Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q1 2021
52 filings reported holding VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value as of Q1 2021.
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.93M shares
of 92.4M outstanding shares and own 10.74% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.61M shares), ORBIMED ADVISORS LLC (1.48M shares), KORNITZER CAPITAL MANAGEMENT INC /KS (720K shares), VANGUARD GROUP INC (711K shares), BlackRock Inc. (701K shares), Altium Capital Management LP (563K shares), Fosun International Ltd (282K shares), FMR LLC (237K shares), STATE STREET CORP (218K shares), and Monashee Investment Management LLC (200K shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.